Top Markets
#1 Islamic Coin Islamic Coin +151.61%
#2 Black Phoenix Black Phoenix +35.36%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.36%
#4 Akedo Akedo +16.92%
#5 Fake World Assets Fake World Assets +15.77%
#6 Palladium Network Palladium Network +15.41%
#7 HOME HOME +12.57%
#8 clBTC clBTC +11.81%
#9 Not in Employment, Education, or Training Not in Employment, Education, or Training +10.75%
#10 MarsCoin MarsCoin +10.60%
Coin of the day
Islamic Coin Islamic Coin
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Kedudukan dalam Saham #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Harga Saham
$0.158
Disegerakkan terakhir: 2026-04-06
Modal Pasaran
$302.92K
Perubahan (1 hari)
16.18%
Perubahan (1 tahun)
-97.91%
Negara
US
Perdagangan Abpro Corporation (ABP)

Kategori

Healthcare
Pendapatan untuk Abpro Corporation (ABP)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini Abpro Corporation, pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi Abpro Corporation dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE